Cxbladder Bulletin - May 2024
Pacific Edge invites you to read the May 2024 edition of the Cxbladder Bulletin. In this issue: AUA 2024: STRATA and Cxbladder Triage Take Center Stage... read more
Survey: Surveillance Patients Show Strong Interest in Non-Invasive Test Options
In December 2023, using the Bladder Cancer Advocacy Network’s (BCAN’s) Patient Survey Network, we surveyed 1,507 US patients being monitored for non-muscle invasive bladder cancer (NMIBC). Those... read more
AUA Journal of Urology Editorial Supports Cxbladder
Pacific Edge welcomes an editorial in the American Urological Association’s Journal of Urology supporting the use of Cxbladder to reduce unnecessary cystoscopies on patients at risk... read more
Pacific Edge on the Podium at UAA in Bali
*Pacific Edge CEO to present data from its recently published STRATA1 study at the Urological Association of Asia (UAA) Congress and attended signing event for lab... read more
New Page
Welcome to the billing and reimbursement page where you can find answers to frequently asked questions. Will my insurance cover the cost of the test? Patients covered... read more
Real World Evidence for Cxbladder to Feature at WSAUA
New data demonstrating the clinical and economic value of Pacific Edge’s Cxbladder cancer diagnostic tests will be in the spotlight at the 100th annual meeting for... read more
Cxbladder Bulletin - October 2024
Pacific Edge invites you to read the October 2024 edition of the Cxbladder Bulletin newsletter. In this issue: Real World Evidence for Cxbladder to Feature at... read more